Report Detail
Global Antibodies Contract Manufacturing Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
- RnM4356917 |
- 03 December, 2021 |
- Global |
- 110 Pages |
- QYResearch |
- Service & Software
Summary:
Market Insights
QY Research has lately published a report titled “Global Antibodies Contract Manufacturing Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application”, with the help of industry-leading research methods, along with observing subtle details and understanding the overall dynamics.
The insights included in this report have been prepared in view of varied aspects that affect the growth. The report elucidates key drivers, trends, prospects, restraining factors, and challenges that players may across in the coming years. With the assistance of this research, players can recognize and capitalize on profitable opportunities. They can further utilize it to make the required advancements in their operations to acquire a competitive advantage over other participants.
The global Antibodies Contract Manufacturing market size is projected to reach US$ million by 2027, from US$ million in 2020, at a CAGR of % during 2021-2027.
Segment Scope
An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including revenue forecast data by type and application for the period 2016-2027. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
Segment by Type
Monoclonal Antibodies
Antibody Fragments
Polyclonal Antibodies
Segment by Application
SME
Large Enterprise
Regional Scope
This segment of the report offers a thorough regional study of the global Antibodies Contract Manufacturing market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate and revenue according to the consumption for the period 2016-2027. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
Key Players
This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue data of manufacturers for the period 2016-2021. Following is the list of key manufacturers observed in this research study:
AMRI
AGC Biologics
Aldevron
Eurofins CDMO
Boehringer Ingelheim BioXcellence
FUJIFILM Diosynth Biotechnologies
Emergent BioSolutions
KBI Biopharma
Lonza
Novasep
Nitto Avecia Pharma Services
Pierre Fabre
Samsung BioLogics
Synthon
Thermo Fisher Scientific
Frequently Asked Questions
Which application segment captured the leading share in the Antibodies Contract Manufacturing market?
How fragmented is the Antibodies Contract Manufacturing market?
Which are the key growth drivers in the Antibodies Contract Manufacturing market?
Which are the top strategies undertaken by the Antibodies Contract Manufacturing market players?
Which technological trends are likely to affect the Antibodies Contract Manufacturing market?
What is the expected Antibodies Contract Manufacturing market size by 2027?
Which companies are dominating the Antibodies Contract Manufacturing market?
Which region is projected to witness the fastest growth in the future?
What factors are restraining the Antibodies Contract Manufacturing market growth?
Which are the emerging companies in the Antibodies Contract Manufacturing market?
Table of Contents
1 Market Overview of Antibodies Contract Manufacturing
- 1.1 Antibodies Contract Manufacturing Market Overview
- 1.1.1 Antibodies Contract Manufacturing Product Scope
- 1.1.2 Antibodies Contract Manufacturing Market Status and Outlook
- 1.2 Global Antibodies Contract Manufacturing Market Size Overview by Region 2016 VS 2021 VS 2027
- 1.3 Global Antibodies Contract Manufacturing Market Size by Region (2016-2027)
- 1.4 Global Antibodies Contract Manufacturing Historic Market Size by Region (2016-2021)
- 1.5 Global Antibodies Contract Manufacturing Market Size Forecast by Region (2022-2027)
- 1.6 Key Regions, Antibodies Contract Manufacturing Market Size (2016-2027)
- 1.6.1 North America Antibodies Contract Manufacturing Market Size (2016-2027)
- 1.6.2 Europe Antibodies Contract Manufacturing Market Size (2016-2027)
- 1.6.3 Asia-Pacific Antibodies Contract Manufacturing Market Size (2016-2027)
- 1.6.4 Latin America Antibodies Contract Manufacturing Market Size (2016-2027)
- 1.6.5 Middle East & Africa Antibodies Contract Manufacturing Market Size (2016-2027)
2 Antibodies Contract Manufacturing Market Overview by Type
- 2.1 Global Antibodies Contract Manufacturing Market Size by Type: 2016 VS 2021 VS 2027
- 2.2 Global Antibodies Contract Manufacturing Historic Market Size by Type (2016-2021)
- 2.3 Global Antibodies Contract Manufacturing Forecasted Market Size by Type (2022-2027)
- 2.4 Monoclonal Antibodies
- 2.5 Antibody Fragments
- 2.6 Polyclonal Antibodies
3 Antibodies Contract Manufacturing Market Overview by Application
- 3.1 Global Antibodies Contract Manufacturing Market Size by Application: 2016 VS 2021 VS 2027
- 3.2 Global Antibodies Contract Manufacturing Historic Market Size by Application (2016-2021)
- 3.3 Global Antibodies Contract Manufacturing Forecasted Market Size by Application (2022-2027)
- 3.4 SME
- 3.5 Large Enterprise
4 Antibodies Contract Manufacturing Competition Analysis by Players
- 4.1 Global Antibodies Contract Manufacturing Market Size by Players (2016-2021)
- 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibodies Contract Manufacturing as of 2020)
- 4.3 Date of Key Players Enter into Antibodies Contract Manufacturing Market
- 4.4 Global Top Players Antibodies Contract Manufacturing Headquarters and Area Served
- 4.5 Key Players Antibodies Contract Manufacturing Product Solution and Service
- 4.6 Competitive Status
- 4.6.1 Antibodies Contract Manufacturing Market Concentration Rate
- 4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
- 5.1 ORDER
- 5.1.1 AMRI Profile
- 5.1.2 AMRI Main Business
- 5.1.3 AMRI Antibodies Contract Manufacturing Products, Services and Solutions
- 5.1.4 AMRI Antibodies Contract Manufacturing Revenue (US$ Million) & (2016-2021)
- 5.1.5 AMRI Recent Developments
- 5.2 AGC Biologics
- 5.2.1 AGC Biologics Profile
- 5.2.2 AGC Biologics Main Business
- 5.2.3 AGC Biologics Antibodies Contract Manufacturing Products, Services and Solutions
- 5.2.4 AGC Biologics Antibodies Contract Manufacturing Revenue (US$ Million) & (2016-2021)
- 5.2.5 AGC Biologics Recent Developments
- 5.3 Aldevron
- 5.3.1 Aldevron Profile
- 5.3.2 Aldevron Main Business
- 5.3.3 Aldevron Antibodies Contract Manufacturing Products, Services and Solutions
- 5.3.4 Aldevron Antibodies Contract Manufacturing Revenue (US$ Million) & (2016-2021)
- 5.3.5 Eurofins CDMO Recent Developments
- 5.4 Eurofins CDMO
- 5.4.1 Eurofins CDMO Profile
- 5.4.2 Eurofins CDMO Main Business
- 5.4.3 Eurofins CDMO Antibodies Contract Manufacturing Products, Services and Solutions
- 5.4.4 Eurofins CDMO Antibodies Contract Manufacturing Revenue (US$ Million) & (2016-2021)
- 5.4.5 Eurofins CDMO Recent Developments
- 5.5 Boehringer Ingelheim BioXcellence
- 5.5.1 Boehringer Ingelheim BioXcellence Profile
- 5.5.2 Boehringer Ingelheim BioXcellence Main Business
- 5.5.3 Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Products, Services and Solutions
- 5.5.4 Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Revenue (US$ Million) & (2016-2021)
- 5.5.5 Boehringer Ingelheim BioXcellence Recent Developments
- 5.6 FUJIFILM Diosynth Biotechnologies
- 5.6.1 FUJIFILM Diosynth Biotechnologies Profile
- 5.6.2 FUJIFILM Diosynth Biotechnologies Main Business
- 5.6.3 FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Products, Services and Solutions
- 5.6.4 FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Revenue (US$ Million) & (2016-2021)
- 5.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments
- 5.7 Emergent BioSolutions
- 5.7.1 Emergent BioSolutions Profile
- 5.7.2 Emergent BioSolutions Main Business
- 5.7.3 Emergent BioSolutions Antibodies Contract Manufacturing Products, Services and Solutions
- 5.7.4 Emergent BioSolutions Antibodies Contract Manufacturing Revenue (US$ Million) & (2016-2021)
- 5.7.5 Emergent BioSolutions Recent Developments
- 5.8 KBI Biopharma
- 5.8.1 KBI Biopharma Profile
- 5.8.2 KBI Biopharma Main Business
- 5.8.3 KBI Biopharma Antibodies Contract Manufacturing Products, Services and Solutions
- 5.8.4 KBI Biopharma Antibodies Contract Manufacturing Revenue (US$ Million) & (2016-2021)
- 5.8.5 KBI Biopharma Recent Developments
- 5.9 Lonza
- 5.9.1 Lonza Profile
- 5.9.2 Lonza Main Business
- 5.9.3 Lonza Antibodies Contract Manufacturing Products, Services and Solutions
- 5.9.4 Lonza Antibodies Contract Manufacturing Revenue (US$ Million) & (2016-2021)
- 5.9.5 Lonza Recent Developments
- 5.10 Novasep
- 5.10.1 Novasep Profile
- 5.10.2 Novasep Main Business
- 5.10.3 Novasep Antibodies Contract Manufacturing Products, Services and Solutions
- 5.10.4 Novasep Antibodies Contract Manufacturing Revenue (US$ Million) & (2016-2021)
- 5.10.5 Novasep Recent Developments
- 5.11 Nitto Avecia Pharma Services
- 5.11.1 Nitto Avecia Pharma Services Profile
- 5.11.2 Nitto Avecia Pharma Services Main Business
- 5.11.3 Nitto Avecia Pharma Services Antibodies Contract Manufacturing Products, Services and Solutions
- 5.11.4 Nitto Avecia Pharma Services Antibodies Contract Manufacturing Revenue (US$ Million) & (2016-2021)
- 5.11.5 Nitto Avecia Pharma Services Recent Developments
- 5.12 Pierre Fabre
- 5.12.1 Pierre Fabre Profile
- 5.12.2 Pierre Fabre Main Business
- 5.12.3 Pierre Fabre Antibodies Contract Manufacturing Products, Services and Solutions
- 5.12.4 Pierre Fabre Antibodies Contract Manufacturing Revenue (US$ Million) & (2016-2021)
- 5.12.5 Pierre Fabre Recent Developments
- 5.13 Samsung BioLogics
- 5.13.1 Samsung BioLogics Profile
- 5.13.2 Samsung BioLogics Main Business
- 5.13.3 Samsung BioLogics Antibodies Contract Manufacturing Products, Services and Solutions
- 5.13.4 Samsung BioLogics Antibodies Contract Manufacturing Revenue (US$ Million) & (2016-2021)
- 5.13.5 Samsung BioLogics Recent Developments
- 5.14 Synthon
- 5.14.1 Synthon Profile
- 5.14.2 Synthon Main Business
- 5.14.3 Synthon Antibodies Contract Manufacturing Products, Services and Solutions
- 5.14.4 Synthon Antibodies Contract Manufacturing Revenue (US$ Million) & (2016-2021)
- 5.14.5 Synthon Recent Developments
- 5.15 Thermo Fisher Scientific
- 5.15.1 Thermo Fisher Scientific Profile
- 5.15.2 Thermo Fisher Scientific Main Business
- 5.15.3 Thermo Fisher Scientific Antibodies Contract Manufacturing Products, Services and Solutions
- 5.15.4 Thermo Fisher Scientific Antibodies Contract Manufacturing Revenue (US$ Million) & (2016-2021)
- 5.15.5 Thermo Fisher Scientific Recent Developments
6 North America
- 6.1 North America Antibodies Contract Manufacturing Market Size by Country (2016-2027)
- 6.2 United States
- 6.3 Canada
7 Europe
- 7.1 Europe Antibodies Contract Manufacturing Market Size by Country (2016-2027)
- 7.2 Germany
- 7.3 France
- 7.4 UK
- 7.5 Italy
- 7.6 Russia
- 7.7 Nordic
- 7.8 Rest of Europe
8 Asia-Pacific
- 8.1 Asia-Pacific Antibodies Contract Manufacturing Market Size by Region (2016-2027)
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australia
- 8.8 Rest of Asia-Pacific
9 Latin America
- 9.1 Latin America Antibodies Contract Manufacturing Market Size by Country (2016-2027)
- 9.2 Mexico
- 9.3 Brazil
- 9.4 Rest of Latin America
10 Middle East & Africa
- 10.1 Middle East & Africa Antibodies Contract Manufacturing Market Size by Country (2016-2027)
- 10.2 Turkey
- 10.3 Saudi Arabia
- 10.4 UAE
- 10.5 Rest of Middle East & Africa
11 Antibodies Contract Manufacturing Market Dynamics
- 11.1 Antibodies Contract Manufacturing Industry Trends
- 11.2 Antibodies Contract Manufacturing Market Drivers
- 11.3 Antibodies Contract Manufacturing Market Challenges
- 11.4 Antibodies Contract Manufacturing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Disclaimer
Summary:
Get latest Market Research Reports on Antibodies Contract Manufacturing. Industry analysis & Market Report on Antibodies Contract Manufacturing is a syndicated market report, published as Global Antibodies Contract Manufacturing Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of Antibodies Contract Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
